Skip to main content

Clinical Trials Using Fluorouracil

Review the clinical trials studying fluorouracil on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 126-150 of 182

Neratinib in Combination with Chemotherapy, Trastuzumab, Pembrolizumab in Patients with Stage HER2 Overexpressing Stage IV Gastroesophageal Cancers
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Chemotherapy with or without Radiation or Surgery in Treating Participants with Oligometastatic Esophageal or Gastric Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Preoperative Hypofractionated Radiotherapy with FOLFOX for the Treatment of Stage I-III Esophageal or Gastroesophageal Junction Adenocarcinoma
Status: Active
Location: 2 locations
Response-Adaptive Chemoradiation after Induction Therapy for the Treatment of Patients with Locally Advanced Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
BMS-986504 and Chemotherapy for the Treatment of Resectable, Locally Advanced, Unresectable, or Metastatic, MTAP-Deleted Pancreatic Ducal Adenocarcinoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Locally Advanced HPV Megative Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Nivolumab, Fluorouracil, and PegInterferon-Alpha2a for the Treatment of Unresectable Fibrolamellar Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Pegcetacoplan in Combination with Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Onvansertib in Combination with NALIRIFOX for the Treatment of Metastatic Pancreatic Cancer
Status: Active
Location: University of Kansas Cancer Center, Kansas City, Kansas
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Fluorouracil with or without Imiquimod for the Treatment of Squamous Cell Carcinoma of the Lower Extremities
Status: Active
Location: UPMC-Saint Margaret, Pittsburgh, Pennsylvania
Chemotherapy with Radiation for the Treatment of Rectal Cancer
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Status: Active
Location: UCHealth University of Colorado Hospital, Aurora, Colorado
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Zunsemetinib with mFOLFIRINOX for the Treatment of Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Adaptive Radiation Therapy Boost for the Treatment of Rectal Cancer, The ARBOR Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Tislelizumab and Pamiparib in Combination with Concurrent Chemotherapy and Radiation Therapy for the Treatment of Patients with Previously Treated Recurrent Head and Neck Squamous Cell Carcinoma
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Aldesleukin in Combination with Nivolumab and Standard Chemotherapy for the Treatment of Gastric Cancer with Peritoneal Metastasis, CONTROL Study
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
9-ING-41 and Retifanlimab with FOLFIRINOX for the Treatment of Advanced Recurrent or Metastatic Pancreatic Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Status: Active
Location: 2 locations